Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
Artesunate
70
CHF
CHF 70.00
In stock
AG-CN2-0469-M100100 mgCHF 70.00
AG-CN2-0469-M500500 mgCHF 210.00
AG-CN2-0469-G0011 gCHF 370.00
Product Details | |
---|---|
Synonyms | Artesunic acid; Qinghaozhi |
Product Type | Chemical |
Properties | |
Formula |
C19H28O8 |
MW | 384.4 |
CAS | 88495-63-0 |
Source/Host Chemicals | Semi-synthetic derivative of artemisinin originally isolated from Artemisia annua. |
Purity Chemicals | ≥98% (HPLC) |
Appearance | White solid. |
Solubility | Soluble in DMSO or ethanol. Sparingly soluble in aqueous buffers. |
InChi Key | FIHJKUPKCHIPAT-AHIGJZGOSA-N |
Smiles | [H][C@@]12CC[C@@H](C)[C@]3([H])CC[C@]4(C)OO[C@@]13[C@]([H])(O[C@@H](OC(=O)CCC(O)=O)[C@@H]2C)O4 |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | +4°C |
Handling Advice |
Keep cool and dry. Protect from light. Protect from moisture and oxygen. |
Use/Stability | Stable for at least 1 year after receipt when stored at +4°C. |
Documents | |
MSDS | Download PDF |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
- Semi-synthetic derivative of artemisinin.
- Anti-malaria.
- Anti-schistosomiasis.
- Inhibitor of human cytomegalovirus (CMV).
- Apoptosis inducer.
- Anti-cancer.
- Immunosuppressant.
- Inhibits production of tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), monocyte chemotactic protein-1 (MCP-1) and nitric oxide (NO).
- Functional ARX inhibitor.
- Enhancer of GABAA signalling.
- Targets Gephyrin.
- Inducer of glucose-6-phosphate dehydrogenase (G6PDH) activity (25fold), the rate limiting enzyme of the pentose phosphate pathway (PPP).
- Sown to have anti-SARS-CoV-2 activity with an EC50 of 12.98 ± 5.30μM, and beeing potentially useful in the treatment of COVID-19.
Product References
- The antimalarial and toxic effect of artesunate on animal models: J. Tradit. Chin. Med. 2, 99 (1982)
- Prevention of red cell lysis in artesunate-treated rats: A role for glucose-6-phosphate dehydrogenase: T.M. Salman; Afr. J. Biotech. 8, 139 (2008)
- Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysis: R. Liu, et al.; Parasit. Vectors 4, 201 (2011)
- Evaluation of the immunosuppressive activity of artesunate in vitro and in vivo: T. Li, et al.; Int. Immunopharmacol. 16, 306 (2013)
- Inhibition of human cytomegalovirus replication by artemisinins: effects mediated through cell cycle modulation: S. Roy, et al.; Antimicrob. Agents Chemother. 59, 3870 (2015)
- Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis: D.E. Jeong, et al.; Oncotarget 6, 33046 (2015)
- Artemisinins target GABAA receptor signaling and impair α cell identity: J. Li, et al.; Cell 168, 86 (2017)
- Anti-SARS-CoV-2 Potential of Artemisinins In Vitro: R. Cao, et al.; ACS Infect. Dis. 6, 2524 (2020)